Health Care Equipment & Services

Hinge Health insider Leslie Kristina M. sold 1,200 Class A shares at $88.23, a routine liquidity move that shows confidence in its clinical pipeline and expansion plans.

Myomo insider sales spark volatility: Kovelman’s latest 17,250‑share sell shows cautious outlook but may fund R&D for future growth.

Insight into Robinson Elliott’s recent $88.42 Hinge Health sell‑off: small block, routine liquidity, no impact on 60% rally or strategy.

Valente Manuela’s $3.20 insider buy of 10k SOPHiA GENETICS shares amid a strong rally signals confidence in the AI‑powered genomic analytics firm’s undervalued future.

Insider CFO Blumberg Scott’s 10‑b‑5‑1 trades reveal disciplined buying, profit‑taking, and confidence in CERIBELL’s AI‑driven diagnostics—key insights for investors.

CEO Chao Xingjuan’s August 18 2026 sale of 2,199 CeriBell shares under a Rule 10b‑5‑1 plan shows disciplined insider trading, not a market risk, as the company’s AI‑driven seizure‑detection tech keeps strong investor confidence.

Senseonics Holdings sees insider buying surge, robust CGM safety data, and expanding FDA approvals—boosting confidence for investors and better diabetes care.

Insight into Surgery Partners’ declining share price and modest insider buying by owner Teresa De Luca, highlighting potential upside if the company improves margins and capitalizes on the outpatient surgical market.

Far​quhar’s latest 32,676‑share sale under a Rule 10b‑5‑1 plan shows disciplined liquidity, not loss of confidence, as HEARTFLOW’s strong earnings and growth keep investors optimistic.

Insight on Stryker’s insider sale: Debra King’s August 18 sale shows routine liquidity moves while the company’s fundamentals remain strong, reassuring long‑term investors.